BDNF prevents NMDA-induced toxicity in models of Huntington's disease: the effects are genotype specific and adenosine A2Areceptor is involved

Excitotoxicity Downregulates TrkB.FL Signaling and Upregulates the Neuroprotective Truncated TrkB Receptors in Cultured Hippocampal and Striatal Neurons

(2012) J. R. Gomes et al.   JOURNAL OF NEUROSCIENCE

The BDNF Val66Met Polymorphism Impairs Synaptic Transmission and Plasticity in the Infralimbic Medial Prefrontal Cortex

(2012) S. S. Pattwell et al.   JOURNAL OF NEUROSCIENCE

Influence of CGS 21680, a selective adenosine A 2A receptor agonist, on NMDA receptor function and expression in the brain of Huntington's disease mice

(2010) Antonella Ferrante et al.   BRAIN RESEARCH

Acute and gradual increases in BDNF concentration elicit distinct signaling and functions in neurons

(2010) Yuanyuan Ji et al.   NATURE NEUROSCIENCE

Adenosine A2Areceptors enable the synaptic effects of cannabinoid CB1receptors in the rodent striatum

(2009) Maria Teresa Tebano et al.   JOURNAL OF NEUROCHEMISTRY

In Vivo Evidence for NMDA Receptor-Mediated Excitotoxicity in a Murine Genetic Model of Huntington Disease

(2009) M. Y. Heng et al.   JOURNAL OF NEUROSCIENCE

Remodeling of striatal NMDA receptors by chronic A2A receptor blockade in Huntington's disease mice

(2009) Alberto Martire et al.   NEUROBIOLOGY OF DISEASE

BDNF Modulation of NMDA Receptors Is Activity Dependent

(2008) Robert A. Crozier et al.   JOURNAL OF NEUROPHYSIOLOGY

Disruption of striatal glutamatergic transmission induced by mutant huntingtin involves remodeling of both postsynaptic density and NMDA receptor signaling

(2007) Jesús F. Torres-Peraza et al.   NEUROBIOLOGY OF DISEASE